Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 2.22 percent decrease over losses of $(0.45) per share from the same period last year.
Return on Capital Employed Overview: Lemonade
Pulled from Benzinga Pro data Lemonade (NYSE:LMND) reported Q2 sales of $28.20 million. Earnings fell to a loss of $58.50 million, resulting in a 11.43% decrease from last quarter.
